Effects of Acyclovir and IVIG on Behavioral Outcomes after HSV1 CNS Infection

Effects of Acyclovir and IVIG on Behavioral Outcomes after HSV1 CNS Infection

Herpes simplex virus 1 (HSV) encephalitis (HSE) has serious neurological complications, involving behavioral and cognitive impairments that cause significant morbidity and a reduced quality of life. We showed that HSE results from dysregulated central nervous system (CNS) inflammatory responses. We...

Full description

Bibliographic Details
Main Authors:	Chandran Ramakrishna, Mari S. Golub, Abby Chiang, Teresa Hong, Markus Kalkum, Edouard M. Cantin
Format:	Article
Language:	English
Published:	Hindawi Limited 2017-01-01
Series:	Behavioural Neurology
Online Access:	http://dx.doi.org/10.1155/2017/5238402

Similar Items

Herpes simplex virus infection, Acyclovir and IVIG treatment all independently cause gut dysbiosis.
by: Chandran Ramakrishna, et al.
Published: (2020-01-01)

IFNγ inhibits G-CSF induced neutrophil expansion and invasion of the CNS to prevent viral encephalitis.
by: Chandran Ramakrishna, et al.
Published: (2018-01-01)

Combined antiviral effects of LAK cells and acyclovir in HSV-1 infection
by: LUO, XUE-XIA, et al.
Published: (1988)

Passively administered pooled human immunoglobulins exert IL-10 dependent anti-inflammatory effects that protect against fatal HSV encephalitis.
by: Chandran Ramakrishna, et al.
Published: (2011-06-01)

Absence of rapid selection for acyclovir or penciclovir resistance following suboptimal oral prodrug therapy of HSV-infected mice
by: Bacon Teresa H, et al.
Published: (2001-12-01)

Establishment of HSV1 latency in immunodeficient mice facilitates efficient in vivo reactivation.
by: Chandran Ramakrishna, et al.
Published: (2015-03-01)

Comparing the Outcomes of IVIg with Combination of IVIg and Methylprednisolone in Children with Acute Idiopathic Thrombocytopenia; a Bayesian Logistic Approach
by: Seyed Kamal Eshagh-Hoseini, et al.
Published: (2016-07-01)

Appropriate indicated use for IVIG in neonatal infections
by: Ying Wang, et al.

Treatment of scleromyxedema with IVIg
by: Moser David W, et al.
Published: (2012-07-01)

Methylprednisolone Pulse Therapy or Additional IVIG for Patients with IVIG-Resistant Kawasaki Disease
by: Zhouping Wang, et al.
Published: (2020-01-01)

Lower dose of intravenous immunoglobulin (I.V.IG) results in comparable outcome in children with newly diagnosed ITP
by: Vineetha Raghavan, et al.
Published: (2016-01-01)

A comparative study of IVIG versus IVIG with IV methylprednisolone in guillain–barre syndrome
by: Rahi Kiran Bhattiprolu, et al.
Published: (2020-01-01)

Small Neutral Amino Acid Ester Prodrugs of Acyclovir Targeting Amino Acid Transporters on the Cornea: Possible Antiviral Agents against Ocular HSV-1 Infections
by: Katragadda Suresh, et al.
Published: (2010-01-01)

Cerebral spinal fluid biomarker profiles in CNS infection associated with HSV and VZV mimic patterns in Alzheimer’s disease
by: Makiko Shinomoto, et al.
Published: (2021-01-01)

Five-year outcomes after IVIG for mild cognitive impairment due to alzheimer disease
by: Shawn Kile, et al.
Published: (2021-08-01)

Timing of infections in patients with primary immunodeficiencies treated with intravenous immunoglobulin (IVIg)
by: Parwinder K. Gill, et al.
Published: (2018-08-01)

Profile of resistance to IVIG treatment in patients with Kawasaki disease and concomitant infection.
by: Audrey Dionne, et al.
Published: (2018-01-01)

Eczematous reaction to IVIG for the treatment of dermatomyositis
by: J. Berk-Krauss, et al.
Published: (2018-09-01)

Development of herpetic infection associated with stroke and its correction with acyclovir
by: Gumenyuk Аlla, et al.
Published: (2017-03-01)

Sensing of HSV-1 by the cGAS–STING pathway in microglia orchestrates antiviral defence in the CNS
by: Line S. Reinert, et al.
Published: (2016-11-01)

The Effects and Pharmacokinetics of Acyclovir in Neonates
by: Gian Maria Pacifici
Published: (2016-12-01)

Acyclovir-induced thrombotic microangiopathy
by: R Goli, et al.
Published: (2017-01-01)

An investigation into the neuroprotective properties of acyclovir
by: Müller, Adrienne Carmel
Published: (2006)

Formulation and Evaluation of Acyclovir Microspheres
by: Pavani s, et al.
Published: (2018-06-01)

IVIG regulates the survival of human but not mouse neutrophils
by: Christoph Schneider, et al.
Published: (2017-05-01)

IVIG Effects on Erythrocyte Sedimentation Rate in Children
by: Farhad Salehzadeh, et al.
Published: (2014-01-01)

Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG?
by: Anne S. De Groot, et al.
Published: (2013-01-01)

Negative epidemiological association between HSV-1 and HSV-2 infections
by: Gheyath K. Nasrallah, et al.
Published: (2019-10-01)

Protocol for a mouse CNS demyelination model induced by a combination of HSV-1 and IL-2
by: Satoshi Hirose, et al.
Published: (2021-03-01)

Kawasaki disease and acute haemolytic anaemia after two IVIG infusions
by: Albena Telcharova-Mihaylovska, et al.
Published: (2016-05-01)

Rapid Resolution of Acute Fulminant Myocarditis after IVIG and Steroid Treatment
by: Michael Barrie, et al.
Published: (2012-01-01)

Economic impact of infections among patients with primary immunodeficiency disease receiving IVIG therapy
by: Menzin J, et al.
Published: (2014-06-01)

Double infections with HSV in the mouse
by: Yirrell, D. L.
Published: (1987)

Tricyclic Derivative of Acyclovir and Its Esters in Relation to the Esters of Acyclovir Enzymatic Stability: Enzymatic Stability Study
by: Izabela Muszalska-Kolos, et al.
Published: (2020-05-01)

Acyclovir Nephrotoxicity: A Case Report Highlighting the Importance of Prevention, Detection, and Treatment of Acyclovir-Induced Nephropathy
by: Raymond Fleischer, et al.
Published: (2010-01-01)

Acyclovir-induced neurotoxicity in an immunocompromised patient
by: Daniel Marks, et al.
Published: (2020-08-01)

The efficacy of acyclovir in treatment of the pemphigus vulgaris
by: Fariba Iraji, et al.
Published: (2013-01-01)

Studying the Effect of Variables on Acyclovir Microsponge
by: Noor Y. Fareed, et al.
Published: (2018-12-01)

The Efficacy of Acyclovir in Childhood Bell’s Palsy
by: Gürkan Gürbüz
Published: (2020-06-01)

Buccal mucoadhesive delivery system of acyclovir
by: Shojaei, Amir Hossein
Published: (1997)

Cannot write session to /tmp/vufind_sessions/sess_glambfbpcvdnoiruab03qfpr4k